1. Home
  2. SABS vs ATER Comparison

SABS vs ATER Comparison

Compare SABS & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • ATER
  • Stock Information
  • Founded
  • SABS 2014
  • ATER 2014
  • Country
  • SABS United States
  • ATER United States
  • Employees
  • SABS N/A
  • ATER N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • SABS Health Care
  • ATER Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • ATER Nasdaq
  • Market Cap
  • SABS 23.9M
  • ATER 25.7M
  • IPO Year
  • SABS N/A
  • ATER N/A
  • Fundamental
  • Price
  • SABS $2.76
  • ATER $2.96
  • Analyst Decision
  • SABS Strong Buy
  • ATER Strong Buy
  • Analyst Count
  • SABS 5
  • ATER 1
  • Target Price
  • SABS $12.40
  • ATER N/A
  • AVG Volume (30 Days)
  • SABS 112.4K
  • ATER 41.1K
  • Earning Date
  • SABS 11-11-2024
  • ATER 11-06-2024
  • Dividend Yield
  • SABS N/A
  • ATER N/A
  • EPS Growth
  • SABS N/A
  • ATER N/A
  • EPS
  • SABS N/A
  • ATER N/A
  • Revenue
  • SABS $2,780,084.00
  • ATER $120,622,000.00
  • Revenue This Year
  • SABS N/A
  • ATER N/A
  • Revenue Next Year
  • SABS N/A
  • ATER $5.45
  • P/E Ratio
  • SABS N/A
  • ATER N/A
  • Revenue Growth
  • SABS N/A
  • ATER N/A
  • 52 Week Low
  • SABS $2.16
  • ATER $0.23
  • 52 Week High
  • SABS $10.50
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • SABS 51.65
  • ATER 49.77
  • Support Level
  • SABS $2.36
  • ATER $2.80
  • Resistance Level
  • SABS $3.21
  • ATER $3.15
  • Average True Range (ATR)
  • SABS 0.24
  • ATER 0.17
  • MACD
  • SABS 0.02
  • ATER 0.02
  • Stochastic Oscillator
  • SABS 47.06
  • ATER 62.96

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: